7-Epi 10-desacetyl paclitaxel
CAS: 78454-17-8
Ref. 3D-IE22703
5mg | 286,00 € | ||
10mg | 420,00 € | ||
25mg | 598,00 € | ||
50mg | 854,00 € | ||
100mg | 1.339,00 € |
Información del producto
- 10-Deacetyl-7-epi-taxol10-Deacetyl-7-epitaxol10-Desacetyl-7-epipaclitaxelPaclitaxel related compound B
- 7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete, benzenepropanoic acid deriv.
- 7-EPI-10-DEACETYL-TAXOL
- Benzenepropanoic acid, β-(benzoylamino)-α-hydroxy-, (2aR,4R,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-
- 7-Epi-10-deacetyltaxol
- 7-epi-10-Deacetyltaxol
- 2'-epi-3'-epi-10-Deacetyltaxol
- 10-Deacetyl-7-epitaxol
7-Epi 10-desacetyl paclitaxel is a prodrug of paclitaxel. It has a similar mechanism of action to paclitaxel, and is used as a chemotherapeutic agent for the treatment of cancer. 7-Epi 10-desacetyl paclitaxel has shown potent apoptotic activity in cell culture, as well as in animal models. This drug is prepared by high performance liquid chromatography and is used to treat cancer. The drug may also be activated by an enzyme called adenosine diphosphate ribose (ADPR), which forms from ATP during cellular metabolism. 7-Epi 10-desacetyl paclitaxel may also have anticancer effects on cervical cancer cells due to its ability to inhibit the synthesis of DNA and RNA.
Propiedades químicas
Consulta técnica sobre: 3D-IE22703 7-Epi 10-desacetyl paclitaxel
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.